Product center

With the tenet of "Healthy China, Dedicated commitment", Linuo Pharmaceuticals increases cooperation and association with external scientific research institutes while innovating and developing independently.

Theophylline Sustained Release Tablets

[Common Name] Theophylline Sustained Release Tablets [Ingredients] The main ingredient of this product is Theophylline. [Character] This product is a white tablet. [Indications] It is suitable for relieving wheezing symptoms such as bronchial asthma, wheezing bronchitis, and obstructive emphysema; it can also be used for wheezing in heart failure.

View details


[Trade Name] Yantongshu [Common Name] Compound Chlorzoxazone Tablets [Ingredients] This product is a compound preparation, each tablet contains 0.125g of Chlorzoxazone and 0.15g of Acetaminophen. [Character] This product is a white tablet. [Indications] Used for various acute skeletal muscle injuries.

View details

Metformin Hydrochloride Tablets

[Common Name] Metformin Hydrochloride Tablets [Ingredients] The main ingredient of this product is Metformin Hydrochloride. [Character] This product is a film-coated tablet, which appears white after removing the coating. [Indications] It is used for type Ⅱ diabetic patients who are unsatisfied with simple diet control, especially those who are obese and accompanied by hyperinsulinemia. The drug not only has the effect of lowering blood sugar, but also may have the effect of reducing weight and hyperinsulinemia. It can be effective for some patients with poor curative effect of sulfonylureas, such as combined with sulfonylureas, intestinal glycosidase inhibitors or thiazolidinedione hypoglycemic drugs, the effect is better than that of single use. It can also be used in patients on insulin therapy to reduce the amount of insulin used.

View details

Gliclazide Tablets

[Common Name] Gliclazide Tablets [Ingredients] The main ingredient of this product is Gliclazide. [Character] This product is a white tablet. [Indications] For type Ⅱ diabetes.

View details
< 1 > proceed page